Get started
Author

Sven L. Klijn

Effectiveness and success factors of educational inhaler technique interventions in asthma & COPD patients: a systematic review
2017 · Sven L. Klijn, Mickaël Hiligsmann, et al. · npj Primary Care Respiratory Medicine · 159
PDF
Introducing the fit-criteria assessment plot – A visualisation tool to assist class enumeration in group-based trajectory modelling
2015 · Sven L Klijn, Matty P Weijenberg, et al. · Statistical Methods in Medical Research · 97
PDF
Artificial Intelligence to Automate Network Meta-Analyses: Four Case Studies to Evaluate the Potential Application of Large Language Models
2024 · Tim Reason, Emma Benbow, et al. · PharmacoEconomics - Open · 85
PDF
Artificial Intelligence to Automate Health Economic Modelling: A Case Study to Evaluate the Potential Application of Large Language Models
2024 · Tim Reason, William Rawlinson, et al. · PharmacoEconomics - Open · 47
PDF
A Guide to Selecting Flexible Survival Models to Inform Economic Evaluations of Cancer Immunotherapies
2022 · Stephen Palmer, Isabelle Borget, et al. · Value in Health · 47
What Did Time Tell Us? A Comparison and Retrospective Validation of Different Survival Extrapolation Methods for Immuno-Oncologic Therapy in Advanced or Metastatic Renal Cell Carcinoma
2021 · Sven L. Klijn, Elisabeth Fenwick, et al. · PharmacoEconomics · 30
Using Generative Artificial Intelligence in Health Economics and Outcomes Research: A Primer on Techniques and Breakthroughs
2025 · Tim Reason, Sven Klijn, et al. · PharmacoEconomics - Open · 26
PDF
Biologic treatment sequences for plaque psoriasis: a cost-utility analysis based on 10 years of Dutch real-world evidence from BioCAPTURE
2017 · S.L. Klijn, J.M.P.A. van den Reek, et al. · British Journal of Dermatology · 14
A Systematic Literature Review of Predictors of Erythropoiesis-Stimulating Agent Failure in Lower-Risk Myelodysplastic Syndromes
2024 · Ralph Boccia, Hong Xiao, et al. · Journal of Clinical Medicine · 9
Budget impact analysis of introducing a non-reconstituted, hexavalent vaccine for pediatric immunization in the United Kingdom
2020 · D. A. R. Mathijssen, M. Heisen, et al. · Expert Review of Vaccines · 9
PDF
Generative Artificial Intelligence to Automate the Adaptation of Excel Health Economic Models and Word Technical Reports
2025 · William Rawlinson, Siguroli Teitsson, et al. · Value in Health · 8
PDF
At the heart of the problem - A person-centred, developmental perspective on the link between alcohol consumption and cardio-vascular events
2016 · Valéria Lima Passos, Sven Klijn, et al. · International Journal of Cardiology · 8
PDF
Estimating and Extrapolating Survival Using a State-Transition Modeling Approach: A Practical Application in Multiple Myeloma
2021 · Istvan Majer, Sonja Kroep, et al. · Value in Health · 6
PDF
Matching-adjusted indirect comparison of lisocabtagene maraleucel versus axicabtagene ciloleucel for second-line treatment of patients with early relapsed or refractory large B-cell lymphoma
2025 · Jeremy S. Abramson, Manali Kamdar, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 5
PDF
Challenges in conducting fractional polynomial and standard parametric network meta-analyses of immune checkpoint inhibitors for first-line advanced renal cell carcinoma
2023 · Svenja Petersohn, Bradley McGregor, et al. · Journal of Comparative Effectiveness Research · 5
Cost-Effectiveness of Nivolumab in Patients with Advanced or Metastatic Renal Cell Carcinoma in Portugal
2016 · K Verleger, AJ Almeida, et al. · Value in Health · 5
Cost-Effectiveness of Nivolumab Plus Ipilimumab for the First-Line Treatment of Intermediate/Poor-Risk Advanced and/or Metastatic Renal Cell Carcinoma in Switzerland
2023 · Esra Çakar, César Oniangue-Ndza, et al. · PharmacoEconomics - Open · 4
PDF
Pcn451 Modeling the Survival Benefit of Immuno-oncologic Therapy: a Review of Methods Used in Nice Single Technology Appraisals
2019 · S. Kroep, C. Kiff, et al. · Value in Health · 4
One-step parametric network meta-analysis models using the exact likelihood that allow for time-varying treatment effects
2025 · Harlan Campbell, Dylan Maciel, et al. · Research Synthesis Methods · 3
PDF
Matching-Adjusted Indirect Comparison (MAIC) of Lisocabtagene Maraleucel (Liso-cel) Versus Axicabtagene Ciloleucel (Axi-cel) for Second-Line (2L) Treatment of Patients (Pt) with Refractory/Early Relapsed (R/R) Large B-Cell Lymphoma (LBCL)
2022 · Jeremy S. Abramson, Manali Kamdar, et al. · Blood · 3
EE494 AI-Driven Virtual Assistance Interface for Excel-Based Economic Model
2024 · S Pandey, R Kaur, et al. · Value in Health · 2
PDF
Matching-Adjusted Indirect Comparison (MAIC) of Lisocabtagene Maraleucel (liso-cel) Versus Axicabtagene Ciloleucel (axi-cel) for Second-Line (2L) Treatment of Patients (pts) with Refractory/Early Relapsed (R/R) Large B-Cell Lymphoma (LBCL): Update with 34 Months of Liso-Cel Follow-up
2024 · Jeremy S. Abramson, Manali Kamdar, et al. · Blood · 2
PDF
EE205 Automating Economic Modeling: Potential of Generative AI for Updating Modeling Reports
2024 · W Rawlinson, S Teitsson, et al. · Value in Health · 2
PDF
P48 Automating Economic Modelling: Potential of Generative AI for Updating Excel-Based Cost-Effectiveness Models
2024 · W. Rawlinson, S. Klijn, et al. · Value in Health · 2
PDF
MSR80 AI-Enabled Risk of Bias Assessment of RCTs in Systematic Reviews: A Case Study
2023 · J. Langham, T. Reason, et al. · Value in Health · 2
Works count: 84
Citation count: 608
H-index: 9
I10-index: 8
Year
Topic
Type